[Clinical studies on cefoperazone in children].
Cefoperazone (CPZ), 50 approximately 200 mg/kg/day, divided into 3 to 4 times/day was drip-infused for 3-20 days to 52 patients (41 patients with acute respiratory tract infection, 6 with urinary tract infection, and 5 with sepsis and/or meningitis. The overall efficacy rate was 92.3%. No adverse reaction was noted. These results indicate the usefulness of CPZ in the treatment of bacterial infections in children.
D002438:Cefoperazone; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D002511:Cephalosporins; D002438:Cefoperazone